Cargando…
Metabolomics-based multidimensional network biomarkers for diabetic retinopathy identification in patients with type 2 diabetes mellitus
INTRODUCTION: Despite advances in diabetic retinopathy (DR) medications, early identification is vitally important for DR administration and remains a major challenge. This study aims to develop a novel system of multidimensional network biomarkers (MDNBs) based on a widely targeted metabolomics app...
Autores principales: | Zuo, Jingjing, Lan, Yuan, Hu, Honglin, Hou, Xiangqing, Li, Jushuang, Wang, Tao, Zhang, Hang, Zhang, Nana, Guo, Chengnan, Peng, Fang, Zhao, Shuzhen, Wei, Yaping, Jia, Chaonan, Zheng, Chao, Mao, Guangyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7888330/ https://www.ncbi.nlm.nih.gov/pubmed/33593748 http://dx.doi.org/10.1136/bmjdrc-2020-001443 |
Ejemplares similares
-
Circulating Metabolites and Lipids Are Associated to Diabetic Retinopathy in Individuals With Type 1 Diabetes
por: Curovic, Viktor Rotbain, et al.
Publicado: (2020) -
Lack of association of genetic variants for diabetic retinopathy in Taiwanese patients with diabetic nephropathy
por: Hsieh, Ai-Ru, et al.
Publicado: (2020) -
Human serum metabolomic analysis reveals progression for high blood pressure in type 2 diabetes mellitus
por: Zhang, Yin, et al.
Publicado: (2021) -
CACNB2 Is a Novel Susceptibility Gene for Diabetic Retinopathy in Type 1 Diabetes
por: Vuori, Nadja, et al.
Publicado: (2019) -
Metabolomic Changes in Serum of Children with Different Clinical Diagnoses of Malnutrition(1)(2)(3)
por: Di Giovanni, Valeria, et al.
Publicado: (2016)